ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Oxford Pharmagenesis Limited

Oxford Pharmagenesis Limited is an active company incorporated on 6 January 1998 with the registered office located in Abingdon, Oxfordshire. Oxford Pharmagenesis Limited was registered 27 years ago.
Status
Active
Active since incorporation
Company No
03488862
Private limited company
Age
27 years
Incorporated 6 January 1998
Size
Medium
Turnover is under £54M
Balance sheet is under £27M
Confirmation
Submitted
Dated 7 January 2025 (9 months ago)
Next confirmation dated 7 January 2026
Due by 21 January 2026 (3 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Nov31 Oct 2024 (1 year)
Accounts type is Full
Next accounts for period 31 October 2025
Due by 31 July 2026 (9 months remaining)
Address
Tubney Warren Barn
Tubney
Oxford
Oxfordshire
OX13 5QJ
Same address for the past 12 years
Telephone
01865390144
Email
Available in Endole App
People
Officers
9
Shareholders
1
Controllers (PSC)
1
Director • Secretary • British • Lives in England • Born in Dec 1977
Director • British • Lives in England • Born in Jul 1971
Director • British • Lives in England • Born in Jan 1973
Director • Consultant • British • Lives in United States • Born in Aug 1966
Director • British • Lives in England • Born in Jan 1975
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Oxford Pharmagenesis Holdings Limited
Dr Graham Anthony Brian Shelton, Dr Richard White, and 1 more are mutual people.
Active
The Northmoor Lion Limited
Dr Graham Anthony Brian Shelton is a mutual person.
Active
Oxford Health Policy Forum Cic
Dr Graham Anthony Brian Shelton is a mutual person.
Active
Brands
Oxford PharmaGenesis
Oxford PharmaGenesis is an independent HealthScience consultancy that provides strategic consultancy in medical communications, medical affairs, and market access.
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Period Ended
31 Oct 2024
For period 31 Oct31 Oct 2024
Traded for 12 months
Cash in Bank
£5.63M
Decreased by £6.33M (-53%)
Turnover
£44.19M
Decreased by £1.36M (-3%)
Employees
416
Increased by 19 (+5%)
Total Assets
£28.33M
Decreased by £5.19M (-15%)
Total Liabilities
-£8.83M
Decreased by £1.01M (-10%)
Net Assets
£19.5M
Decreased by £4.19M (-18%)
Debt Ratio (%)
31%
Increased by 1.83% (+6%)
Latest Activity
Full Accounts Submitted
5 Months Ago on 9 May 2025
Confirmation Submitted
9 Months Ago on 8 Jan 2025
Sharon Michele Frost Resigned
10 Months Ago on 29 Nov 2024
Graham Anthony Brian Shelton Resigned
11 Months Ago on 24 Oct 2024
Mr Christopher Philip Rains Appointed
1 Year 4 Months Ago on 1 Jun 2024
Full Accounts Submitted
1 Year 4 Months Ago on 14 May 2024
Confirmation Submitted
1 Year 8 Months Ago on 12 Jan 2024
Brian Falcone Resigned
2 Years 4 Months Ago on 1 Jun 2023
Full Accounts Submitted
2 Years 5 Months Ago on 3 May 2023
Charge Satisfied
2 Years 6 Months Ago on 13 Mar 2023
Get Credit Report
Discover Oxford Pharmagenesis Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 October 2024
Submitted on 9 May 2025
Confirmation statement made on 7 January 2025 with no updates
Submitted on 8 Jan 2025
Termination of appointment of Sharon Michele Frost as a director on 29 November 2024
Submitted on 16 Dec 2024
Termination of appointment of Graham Anthony Brian Shelton as a director on 24 October 2024
Submitted on 7 Nov 2024
Appointment of Mr Christopher Philip Rains as a director on 1 June 2024
Submitted on 14 Jun 2024
Full accounts made up to 31 October 2023
Submitted on 14 May 2024
Confirmation statement made on 7 January 2024 with no updates
Submitted on 12 Jan 2024
Termination of appointment of Brian Falcone as a director on 1 June 2023
Submitted on 9 Jun 2023
Full accounts made up to 31 October 2022
Submitted on 3 May 2023
Satisfaction of charge 034888620005 in full
Submitted on 13 Mar 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year